MMLV Reverse Transcriptase Mutants for Thermostable cDNA Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing MMLV and AMV reverse transcriptase enzymes face limitations in thermostability and RNase H activity, leading to reduced efficiency and fidelity in synthesizing cDNA from RNA templates, especially those with strong secondary structures or longer lengths.
Innovation Solution
Development of MMLV reverse transcriptase mutants with specific amino acid substitutions, such as I61R, Q68R, Q79R, L99R, and E282D, to enhance thermostability and reduce RNase H activity, improving cDNA synthesis efficiency and fidelity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If MMLV RTase is used for reverse transcription, then fidelity and low RNase H activity are achieved, but thermostability and ability to handle strong secondary structures are limited
Solution Approach 1:
The patent applies parameter changes by introducing specific amino acid substitutions (I61R, Q68R, Q79R, L99R, E282D) into the MMLV RTase sequence to alter the enzyme's physical properties. These substitutions change the protein's thermostability and structural characteristics while preserving its catalytic function, enabling the enzyme to maintain fidelity at elevated temperatures.
2Stability of the object's composition
If AMV RTase is used to improve thermostability, then ability to handle strong secondary structures is enhanced, but RNase H activity increases causing reduced cDNA yield and fidelity
Solution Approach 1:
The patent extracts the harmful RNase H activity from the reverse transcription system by using MMLV RTase variants with reduced or eliminated RNase H function. This allows the beneficial thermostability to be retained while removing the detrimental RNA degradation that occurs with AMV RTase.
Solution Approach 2:
The patent modifies the enzyme's parameters through amino acid substitutions that specifically reduce RNase H activity while maintaining or enhancing thermostability. The E282D substitution and other changes alter the enzyme's properties to achieve low RNase H activity combined with improved thermal stability.
3Adaptability or versatility
If MMLV RTase is used at elevated temperatures to resolve secondary structures, then secondary structure handling is improved, but enzyme activity and cDNA length/yield decrease
Solution Approach 1:
The patent changes the enzyme's thermal parameters through amino acid substitutions that increase thermostability. This allows the enzyme to maintain optimal activity at elevated temperatures (up to 50-55°C), enabling effective secondary structure resolution while preserving catalytic efficiency and cDNA yield.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mutants exhibit increased RTase activity and thermostability, enabling more efficient and accurate cDNA synthesis from RNA templates, even at elevated temperatures, overcoming the limitations of wild-type and existing mutants.
Implementation Method 1
RTase is a critical component of the reverse transcription polymerase chain reaction (RT-PCR) allowing the production of complementary DNA (cDNA) from RNA
Implementation Method 2
RNase H, a non-sequence-specific endonuclease enzyme that catalyzes cleavage of RNA in an RNA/DNA duplex
Data Source
AI summary
The disclosure provides Moloney murine leukemia virus (MMLV) reverse transcriptase (RTase) mutants. The disclosure as provides suitable amino acid positions in MMLV RTase for mutagenesis and methods and kits for using MMLV RTase mutants to synthesize cDNA from RNA templates.